EPA-0666 – Long-term Maintenance of Efficacy of Extended-Release Guanfacine Hydrochloride (GXR) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD): Double-Blind, Placebo-Controlled, Multicentre, Phase 3 Randomized Withdrawal Study